Zhang L - Search Results

1

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.

Tang A, Chen Z, Cox KS, Su HP, Callahan C, Fridman A, Zhang L, Patel SB, Cejas PJ, Swoyer R, Touch S, Citron MP, Govindarajan D, Luo B, Eddins M, Reid JC, Soisson SM, Galli J, Wang D, Wen Z, Heidecker GJ, Casimiro DR, DiStefano DJ, Vora KA. Tang A, et al. Among authors: zhang l. Nat Commun. 2019 Sep 12;10(1):4153. doi: 10.1038/s41467-019-12137-1. Nat Commun. 2019. PMID: 31515478 Free PMC article.

2

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein.

Chen Z, Zhang L, Tang A, Callahan C, Pristatsky P, Swoyer R, Cejas P, Nahas D, Galli J, Cosmi S, DiStefano D, Hoang VM, Bett A, Casimiro D, Vora KA. Chen Z, et al. Among authors: zhang l. PLoS One. 2016 Jun 3;11(6):e0156798. doi: 10.1371/journal.pone.0156798. eCollection 2016. PLoS One. 2016. PMID: 27258388 Free PMC article.

3

Improving the immunogenicity of a trivalent Neisseria meningitidis native outer membrane vesicle vaccine by genetic modification.

Zhang L, Wen Z, Lin J, Xu H, Herbert P, Wang XM, Mehl JT, Ahl PL, Dieter L, Russell R, Kosinski MJ, Przysiecki CT. Zhang L, et al. Vaccine. 2016 Jul 29;34(35):4250-4256. doi: 10.1016/j.vaccine.2016.05.049. Epub 2016 Jul 2. Vaccine. 2016. PMID: 27269057 Free article.

4

Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.

Wen Z, Boddicker MA, Kaufhold RM, Khandelwal P, Durr E, Qiu P, Lucas BJ, Nahas DD, Cook JC, Touch S, Skinner JM, Espeseth AS, Przysiecki CT, Zhang L. Wen Z, et al. Among authors: zhang l. BMC Microbiol. 2016 Jul 27;16(1):165. doi: 10.1186/s12866-016-0787-3. BMC Microbiol. 2016. PMID: 27464881 Free PMC article.

5

Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.

Flynn JA, Durr E, Swoyer R, Cejas PJ, Horton MS, Galli JD, Cosmi SA, Espeseth AS, Bett AJ, Zhang L. Flynn JA, et al. Among authors: zhang l. PLoS One. 2016 Oct 20;11(10):e0164789. doi: 10.1371/journal.pone.0164789. eCollection 2016. PLoS One. 2016. PMID: 27764150 Free PMC article.

6

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.

Zhang L, Durr E, Galli JD, Cosmi S, Cejas PJ, Luo B, Touch S, Parmet P, Fridman A, Espeseth AS, Bett AJ. Zhang L, et al. Vaccine. 2018 Dec 18;36(52):8119-8130. doi: 10.1016/j.vaccine.2018.10.032. Epub 2018 Oct 16. Vaccine. 2018. PMID: 30340881

7

Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.

Wen Z, Citron M, Bett AJ, Espeseth AS, Vora KA, Zhang L, DiStefano DJ. Wen Z, et al. Among authors: zhang l. J Virol Methods. 2019 Jan;263:88-95. doi: 10.1016/j.jviromet.2018.10.022. Epub 2018 Oct 28. J Virol Methods. 2019. PMID: 30381239 Free article.

8

Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes.

Xiao X, Tang A, Cox KS, Wen Z, Callahan C, Sullivan NL, Nahas DD, Cosmi S, Galli JD, Minnier M, Verma D, Babaoglu K, Su H, Bett AJ, Vora KA, Chen Z, Zhang L. Xiao X, et al. Among authors: zhang l. MAbs. 2019 Nov-Dec;11(8):1415-1427. doi: 10.1080/19420862.2019.1654304. Epub 2019 Aug 23. MAbs. 2019. PMID: 31402751 Free PMC article.

9

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.

Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S, Wen Z, Antonello J, Zhang L, Flynn JA, Cox KS, Freed DC, Vora KA, Bahl K, Latham AH, Smith JS, Gindy ME, Ciaramella G, Hazuda D, Shaw CA, Bett AJ. Espeseth AS, et al. Among authors: zhang l. NPJ Vaccines. 2020 Feb 14;5(1):16. doi: 10.1038/s41541-020-0163-z. eCollection 2020. NPJ Vaccines. 2020. PMID: 32128257 Free PMC article.

10

Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development.

Galli JD, Horton M, Durr E, Heidecker GJ, Freed D, Fridman A, Wang D, Zhang L. Galli JD, et al. Among authors: zhang l. Vaccines (Basel). 2022 Jan 25;10(2):184. doi: 10.3390/vaccines10020184. Vaccines (Basel). 2022. PMID: 35214644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124,493 results

Search Page